daunorubicin has been researched along with Carcinoma, Hepatocellular in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (41.67) | 18.7374 |
1990's | 10 (27.78) | 18.2507 |
2000's | 7 (19.44) | 29.6817 |
2010's | 3 (8.33) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Chen, YY; Fu, LX; Gan, RZ; Li, L; Liang, G; Lv, MX; Zhang, XX; Zhou, H; Zhou, JL; Zhu, HQ | 1 |
Albi, E; Ambesi-Impiombato, FS; Arcuri, C; Beccari, T; Cataldi, S; Ceccarini, MR; Codini, M; Conte, C; Curcio, F; Floridi, A; Lazzarini, A; Mecca, C; Patria, F | 1 |
Csík, G; Hudecz, F; Magyar, A; Miklán, Z; Orbán, E; Schlosser, G | 1 |
Dang, Y; Ding, L; Hu, H; Hu, X; Huang, Q; Huang, W; Ji, X; Jiang, S; Li, J; Liu, JO; Liu, S; Shen, S; Yang, X; Yu, L | 1 |
Baggetto, LG; Barakat, S; Magnard, S; Michaud, M; Rigal, D | 1 |
Lei, S; Lin, P; Lin, QY; Liu, ZM; Luo, HY; Yan, LN; Yang, JY; Zhang, J | 1 |
Coll, O; Fernández-Checa, JC; García-Ruiz, C; Morales, A; Paris, R; Sánchez-Reyes, A | 1 |
DASDIA, T; DIMARCO, A; GAETANI, M; OREZZI, P; SCARPINATO, BM; SILVESTRINI, R; SOLDATI, M; VALENTINI, L | 1 |
CALENDI, E; DIMARCO, A; REGGIANI, M; SCARPINATO, B; VALENTINI, L | 1 |
Lin, QY; Liu, ZM; Luo, HY; Yan, LN; Yang, JY | 1 |
Chen, L; Gou, XH; Han, L; Li, DH; Yan, LN | 1 |
Fernández-Checa, JC; García-Ruiz, C; Llacuna, L; Morales, A; París, R; Villanueva, A | 1 |
Jollès, G; Trouet, A | 1 |
Miwa, A; Okada, Y; Tominaga, M; Tominaga, T | 1 |
Arias, IM; Fantappié, O; Gatmaitan, Z; Gentilini, P; Kamimoto, Y; Mazzanti, R | 1 |
Clausen, OP; De Angelis, P; Lehne, G; Rugstad, HE | 2 |
Anderson, D; Boivin, CM; Christodoulou, C; Daryani, S; David, M; Doran, J; Ferry, DR; Hesslewood, S; Julyan, PJ; Kerr, DJ; Seymour, LW; Young, AM | 1 |
Egawa, K; Seo, N; Takigawa, M; Tokura, Y | 1 |
Chan, AT; Chan, KK; Ho, S; Johnson, PJ; Leung, WT; Mukwaya, G; Ross, M; Yeo, W | 1 |
Cao, D; Chung, SS; Jiang, Z; Ko, BC; Lee, KW | 1 |
Abe, I; Sato, S | 1 |
Coetzee, ML; Klein, K; Ove, P; Sartiano, GP | 2 |
Brucksch, KP; Schmidt, CG; Seeber, B; Seeber, S | 1 |
Carlhant, D; Glaise, D; Guillouzo, A; Kernaleguen, D; Le Bot, MA; Ratanasavanh, D; Riche, C | 1 |
Hironaka, T; Horiike, S; Kashima, K; Misawa, S; Nakagawa, H; Nishigaki, H; Shizumi, Y; Takashima, T; Tanaka, S; Taniwaki, M | 1 |
Kukita, K | 1 |
Chytrý, V; Duncan, R; Hume, IC; Kopecek, J; Kopecková, P; O'Hare, KB; Scarlett, L | 1 |
Aso, T; Hino, H; Hirota, Y; Kondou, S; Makuuchi, M; Matsumoto, I; Nishiura, S; Takata, K | 1 |
Baurain, R; Ceulemans, F; Geubel, A; Lesur, B; Rolin-van Swieten, D; Trouet, A | 1 |
Cheng, CC; Zee-Cheng, KY | 1 |
Locatelli, P; Prina, C; Roveta, G | 1 |
Hisamatsu, T; Koeda, T | 1 |
Omi, K | 1 |
Ishihara, Y; Kitaura, K; Takahira, H; Watanabe, Y | 1 |
3 review(s) available for daunorubicin and Carcinoma, Hepatocellular
Article | Year |
---|---|
Targeting of daunorubicin by association with DNA or proteins: a review.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies; Breast Neoplasms; Carcinoma, Hepatocellular; Daunorubicin; DNA; Heart; Humans; Liver Neoplasms; Naphthacenes; Proteins; Serum Albumin | 1984 |
Acute erythroleukemia with t(3;5) accompanied by hepatocellular carcinoma.
Topics: Aclarubicin; Adolescent; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Carcinoma, Hepatocellular; Child; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 5; Cytarabine; Daunorubicin; Doxorubicin; Female; Hepatectomy; Hepatitis B; Humans; Leukemia, Erythroblastic, Acute; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prednisolone; Remission Induction; Translocation, Genetic | 1991 |
Some antineoplastic antibiotics.
Topics: Adenocarcinoma; Amino Sugars; Animals; Antibiotics, Antineoplastic; Azaserine; Benzazepines; Bleomycin; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cricetinae; Dactinomycin; Daunorubicin; DNA; Dogs; Glycosides; Haplorhini; Humans; Leukemia L1210; Liver Neoplasms; Lymphoma; Mice; Mitomycins; Naphthacenes; Plicamycin; Pyrroles; Rats; RNA; Sarcoma 180; Streptonigrin; Streptozocin | 1972 |
2 trial(s) available for daunorubicin and Carcinoma, Hepatocellular
Article | Year |
---|---|
Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine.
Topics: Antibiotics, Antineoplastic; Biotransformation; Carcinoma, Hepatocellular; Daunorubicin; Drug Carriers; Galactosamine; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Polymethacrylic Acids; Tomography, Emission-Computed, Single-Photon; Whole-Body Counting | 1999 |
Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Daunorubicin; Drug Carriers; Female; Humans; Liposomes; Liver Neoplasms; Male; Middle Aged | 1999 |
31 other study(ies) available for daunorubicin and Carcinoma, Hepatocellular
Article | Year |
---|---|
The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
Topics: Alcohol Oxidoreductases; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Carcinoma, Hepatocellular; Cardiotoxicity; Catechin; Cell Proliferation; Daunorubicin; Drug Synergism; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Heart Rate; Hep G2 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Nucleus; Cholesterol; Daunorubicin; Down-Regulation; Drug Resistance, Neoplasm; Golgi Matrix Proteins; Humans; Lamin Type B; Liver Neoplasms; Membrane Microdomains; Sphingomyelin Phosphodiesterase; Sphingomyelins; STAT3 Transcription Factor | 2018 |
New daunomycin-oligoarginine conjugates: synthesis, characterization, and effect on human leukemia and human hepatoma cells.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Daunorubicin; Drug Screening Assays, Antitumor; Hep G2 Cells; HL-60 Cells; Humans; Leukemia; Peptides | 2009 |
Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.
Topics: Alcohol Oxidoreductases; Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Carcinoma, Hepatocellular; Catechin; Daunorubicin; Humans; Liver Neoplasms; Mice; Tumor Cells, Cultured | 2010 |
Leucine-rich protein 130 contributes to apoptosis resistance of human hepatocarcinoma cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Daunorubicin; Down-Regulation; Drug Resistance, Neoplasm; Genetic Vectors; Hep G2 Cells; Humans; Lentivirus; Liver Neoplasms; Microscopy, Fluorescence; Neoplasm Proteins; RNA Interference; RNA, Small Interfering; Transfection | 2011 |
Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Genes, MDR; Humans; Liver Neoplasms; Phenotype; Subcellular Fractions; Tumor Cells, Cultured | 2002 |
Ganglioside GD3 sensitizes human hepatoma cells to cancer therapy.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Carrier Proteins; Caspase 3; Caspases; Cytochrome c Group; Daunorubicin; Dose-Response Relationship, Drug; Enzyme Activation; Gangliosides; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Microscopy, Confocal; Mitochondria; Mitochondrial Proteins; Models, Genetic; NF-kappa B; Phosphorylation; Plasmids; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Radiation-Sensitizing Agents; Reactive Oxygen Species; Signal Transduction; Time Factors; Transcription Factor RelA; Transcriptional Activation; Up-Regulation | 2002 |
'DAUNOMYCIN', A NEW ANTIBIOTIC OF THE RHODOMYCIN GROUP.
Topics: Animals; Anthracyclines; Anti-Bacterial Agents; Antimetabolites; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Daunorubicin; DNA; DNA, Neoplasm; Glycosides; Liver Neoplasms; Mice; Pharmacology; Polarography; Rats; Research; RNA; RNA, Neoplasm; Ultraviolet Rays | 1964 |
ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS.
Topics: Anti-Bacterial Agents; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry, Physical; Coliphages; Daunorubicin; Deoxyribonucleases; DNA; Liver Neoplasms; Magnesium; Nucleic Acids; Polarography; Research; RNA; Spectrophotometry; Streptomyces; Thymus Gland; Tissue Culture Techniques; Ultracentrifugation; Ultraviolet Rays; Viscosity | 1965 |
[Reversal of multidrug resistance gene MDR1 and MRP of drug-resistant human hepatocellular carcinoma cells SMMC-7721/ADM with antisense phosphorothioate oligonucleotides].
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Genes, MDR; Humans; Liver Neoplasms; Multidrug Resistance-Associated Proteins; Oligonucleotides, Antisense; Rhodamine 123 | 2004 |
[Reversal of the multidrug resistance in human hepatocellular carcinoma cells by recombinant adenoviral delivery of the MRP antisense RNA in vitro].
Topics: Adenoviridae; Carcinoma, Hepatocellular; Cell Line, Tumor; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Multidrug Resistance-Associated Proteins; RNA, Antisense; Transfection | 2005 |
Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo.
Topics: Animals; Carcinoma, Hepatocellular; Caspase 3; Cell Proliferation; Daunorubicin; Drug Therapy; Endocannabinoids; Ethanolamines; Galactosylgalactosylglucosylceramidase; Humans; Lysophospholipids; Mice; Microscopy, Electron, Transmission; Mitochondria; Oleic Acids; Protease Inhibitors; RNA, Messenger; RNA, Small Interfering; Sphingosine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2007 |
Volume-sensitive chloride channel activity does not depend on endogenous P-glycoprotein.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Chloride Channels; Daunorubicin; Diglycerides; DNA Primers; Drug Resistance, Multiple; Epithelium; Humans; Intestine, Small; Liver Neoplasms; Membrane Potentials; Molecular Sequence Data; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; Polymerase Chain Reaction; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vincristine | 1995 |
Bile acid inhibition of P-glycoprotein-mediated transport in multidrug-resistant cells and rat liver canalicular membrane vesicles.
Topics: Animals; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bile Acids and Salts; Bile Canaliculi; Biological Transport; Carcinoma, Hepatocellular; Carrier Proteins; Cell Membrane; Daunorubicin; Depression, Chemical; Doxorubicin; Drug Resistance; Liver Neoplasms; Male; Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1994 |
Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
Topics: Aclarubicin; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cell Division; Cell Membrane; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epirubicin; Humans; Liver Neoplasms; Microscopy, Confocal; Tumor Cells, Cultured | 1996 |
Differential resistance to anthracyclines in P-glycoprotein-expressing human hepatoma cells.
Topics: Aclarubicin; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Epirubicin; Humans; Liver Neoplasms; Tumor Cells, Cultured | 1998 |
Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Antibody Specificity; Carcinoma, Hepatocellular; Cytokines; Cytotoxicity, Immunologic; Daunorubicin; Interleukin-10; Killer Cells, Natural; Lymphocyte Depletion; Lymphocytes, Tumor-Infiltrating; Male; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Receptors, Antigen, T-Cell, gamma-delta; Suppressor Factors, Immunologic; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; Transforming Growth Factor beta; Tumor Cells, Cultured | 1999 |
Overexpression of aldose reductase in liver cancers may contribute to drug resistance.
Topics: Aldehyde Reductase; Antibiotics, Antineoplastic; Blotting, Northern; Carcinoma, Hepatocellular; Cell Survival; Daunorubicin; Drug Resistance, Neoplasm; Enzyme Induction; Enzyme Inhibitors; Gene Expression; Humans; L-Lactate Dehydrogenase; Liver Neoplasms; RNA, Messenger; Tumor Cells, Cultured | 2001 |
Beta-glucuronidase activity of Yoshida ascites hepatomas of different drug-sensitivity and its change after treatment of host rats with various anticancer agents.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carbazilquinone; Carcinoma, Hepatocellular; Chromomycins; Cyclophosphamide; Cytarabine; Daunorubicin; Deoxyribonucleases; Fluorouracil; Glucuronidase; Liver Neoplasms; Male; Mesylates; Mitomycins; Neoplasms, Experimental; Nitro Compounds; Rats; Sarcoma, Yoshida; Tosyl Compounds; Vincristine; Zinostatin | 1976 |
Inhibition of bleomycin-induced [3H] thymidine 5'-triphosphate incorporation into liver and hepatoma nuclei by N-ethyl maleimide and daunomycin.
Topics: Animals; Binding Sites; Binding, Competitive; Bleomycin; Carcinoma, Hepatocellular; Cell Nucleus; Daunorubicin; DNA; In Vitro Techniques; Liver; Liver Neoplasms; Male; Maleimides; Rats; Thymine Nucleotides | 1977 |
The effect of several antitumor agents on 3H-TTP incorporation in host liver and hepatoma nuclei.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Camptothecin; Carcinoma, Hepatocellular; Cell Nucleus; Daunorubicin; DNA; DNA, Neoplasm; DNA, Single-Stranded; Doxorubicin; In Vitro Techniques; Liver; Liver Neoplasms; Male; Mitomycins; Neoplasms, Experimental; Plicamycin; Rats; Thymidine | 1977 |
Cytostatic efficacy of DNA-complexes of adriamycin, daunomycin and actinomycin D. I. Comparative studies in Novikoff hepatoma, human mammary carcinoma cells and human leukemic leukocytes.
Topics: Acute Disease; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Dactinomycin; Daunorubicin; DNA, Neoplasm; Doxorubicin; Female; Humans; Leukemia; Liver Neoplasms; Pinocytosis; Rats; RNA, Neoplasm | 1977 |
Metabolism of doxorubicin, daunorubicin and epirubicin in human and rat hepatoma cells.
Topics: Animals; Biotransformation; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Epirubicin; Humans; Liver; Rats; Tumor Cells, Cultured | 1991 |
[Cytotoxic effect of anticancer drug combined with anti-AFP antibody on human hepatoma cell in vitro].
Topics: alpha-Fetoproteins; Antibodies; Carcinoma, Hepatocellular; Cell Survival; Daunorubicin; Humans; Immunotoxins; Liver Neoplasms; Tumor Cells, Cultured | 1990 |
Effect of galactose on interaction of N-(2-hydroxypropyl)methacrylamide copolymers with hepatoma cells in culture: preliminary application to an anticancer agent, daunomycin.
Topics: Acrylamides; Animals; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Daunorubicin; Drug Carriers; Galactose; Humans; Liver Neoplasms; Mice; Polymers; Rats; Time Factors; Tumor Cells, Cultured | 1989 |
[Hepatocellular carcinoma treated with a curative segmentectomy five years after complete remission of acute myeloblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Combined Modality Therapy; Cytarabine; Daunorubicin; Embolization, Therapeutic; Hepatectomy; Hepatitis B Surface Antigens; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Male; Mercaptopurine; Middle Aged; Neoplasms, Multiple Primary; Prednisolone; Remission Induction | 1989 |
[Targeting of anthracyclines and hepatomas].
Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Daunorubicin; Drug Combinations; Drug Evaluation; Humans; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Nude; Middle Aged; Serum Albumin | 1987 |
[Action of surface-active agents (Triton X 100, Osofor) and of an antimitotic drug (Daunomycin) on cells of ascites tumors].
Topics: Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cell Division; Daunorubicin; Liver Neoplasms; Mice; Rats; Sarcoma, Yoshida; Surface-Active Agents | 1965 |
Effects of neopluramycin on ascites tumors implanted in experimental animals.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Daunorubicin; Female; Injections, Intraperitoneal; Leukemia; Liver Neoplasms; Male; Mice; Neoplasms, Experimental; Rats | 1971 |
[In vitro cytotoxic effects of antineoplastic agents on malignant tumor cells derived from children].
Topics: Carcinoma, Hepatocellular; Child, Preschool; Cyclophosphamide; Dactinomycin; Daunorubicin; Female; Humans; In Vitro Techniques; Infant; Liver Neoplasms; Male; Neuroblastoma; Vincristine; Wilms Tumor | 1971 |
[Antitumor activity of adriamycin].
Topics: Administration, Oral; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cyclophosphamide; Daunorubicin; Doxorubicin; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Lethal Dose 50; Leukemia L1210; Liver Neoplasms; Lymphoma; Male; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Mitomycins; Neoplasms, Experimental; Rats; Sarcoma 180; Sarcoma, Yoshida | 1972 |